High Relaxivity Magnetic Resonance Imaging Contrast Agents Part 1: Impact of Single Donor Atom Substitution on Relaxivity of Serum Albumin-Bound Gadolinium Complexes

Rationale and Objectives:The donor atoms that bind to gadolinium in contrast agents influence inner-sphere water exchange and electronic relaxation, both of which determine observed relaxivity. The effect of these molecular parameters on relaxivity is greatest when the contrast agent is protein bound. We sought to determine an optimal donor atom set to yield high relaxivity compounds. Methods:A total of 38 gadolinium-1,4,7,10-tetraazacyclo-dodecane-N,N′,N′′,N′′′-tetraacetato derivatives were prepared and relaxivity was determined in the presence and absence of human serum albumin as a function of temperature and magnetic field. Each compound had a common albumin-binding group and differed only by substitution of different donor groups at one of the macrocycle nitrogens. Oxygen-17 isotope relaxometry at 7.05 T was performed to estimate water exchange rates. Results:Changing a single donor atom resulted in changes in water exchange rates ranging across 3 orders of magnitude. Donor groups increased water exchange rate in the order: phosphonate ∼ phenolate > &agr;-substituted acetate > acetate > hydroxamate ∼ sulfonamide > amide ∼ pyridyl ∼ imidazole. Relaxivites at 0.47 and 1.4 T, 37°C, ranged from 12.3 to 55.6 mM−1s−1 and from 8.3 to 32.6 mM−1s−1 respectively. Optimal relaxivities were observed when the donor group was an &agr;-substituted acetate. Electronic relaxation was slowest for the acetate derivatives as well. Conclusions:Water exchange dynamics and relaxivity can be predictably tuned by choice of donor atoms.

[1]  Enzo Terreno,et al.  Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. , 2009, Accounts of chemical research.

[2]  A. Trzeciak,et al.  A Simple and Effective Chemical Phosphorylation Procedure for Biomolecules , 1987 .

[3]  Paul Jurek,et al.  Potentiometric and relaxometric properties of a gadolinium-based MRI contrast agent for sensing tissue pH. , 2007, Inorganic chemistry.

[4]  M. Port,et al.  Correlation of Water Exchange Rate with Isomeric Composition in Diastereoisomeric Gadolinium Complexes of Tetra(carboxyethyl)dota and Related Macrocyclic Ligands , 2000 .

[5]  Joop A. Peters,et al.  Lanthanide(III) complexes of a mono(methylphosphonate) analogue of H4dota: the influence of protonation of the phosphonate moiety on the TSAP/SAP isomer ratio and the water exchange rate. , 2005, Chemistry.

[6]  Seymour H. Koenig,et al.  Field-cycling relaxometry of protein solutions and tissue: Implications for MRI , 1990 .

[7]  Thomas J Meade,et al.  Bioresponsive, cell-penetrating, and multimeric MR contrast agents. , 2009, Accounts of chemical research.

[8]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[9]  M. Botta,et al.  Ternary Gd(III)L-HSA adducts: evidence for the replacement of inner-sphere water molecules by coordinating groups of the protein. Implications for the design of contrast agents for MRI , 2000, JBIC Journal of Biological Inorganic Chemistry.

[10]  A. Sautter,et al.  Photoinduced Electron and Energy Transfer Processes in a Bichromophoric Pyrene-Perylene Bisimide System , 2004 .

[11]  M. Caruthers,et al.  In situ activation of bis-dialkylaminophosphines--a new method for synthesizing deoxyoligonucleotides on polymer supports. , 1984, Nucleic acids research.

[12]  M. Port,et al.  A high-frequency EPR study of frozen solutions of Gd(III) complexes: straightforward determination of the zero-field splitting parameters and simulation of the NMRD profiles. , 2006, Journal of the American Chemical Society.

[13]  Peter Caravan,et al.  Determination of the hydration number of gadolinium(III) complexes by high-field pulsed 17O ENDOR spectroscopy. , 2006, Chemphyschem : a European journal of chemical physics and physical chemistry.

[14]  Peter Caravan,et al.  The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. , 2002, Journal of the American Chemical Society.

[15]  S. Bott,et al.  Synthesis, relaxometric and photophysical properties of a new pH-responsive MRI contrast agent: the effect of other ligating groups on dissociation of a p-nitrophenolic pendant arm. , 2004, Journal of the American Chemical Society.

[16]  H. Thomsen,et al.  High Prevalence of Nephrogenic Systemic Fibrosis in Chronic Renal Failure Patients Exposed to Gadodiamide, a Gadolinium-Containing Magnetic Resonance Contrast Agent , 2008, Investigative radiology.

[17]  J. Kowalewski,et al.  Nuclear spin relaxation in paramagnetic systems (S>/=1) under fast rotation conditions. , 2003, Journal of magnetic resonance.

[18]  I. Solomon Relaxation Processes in a System of Two Spins , 1955 .

[19]  C. Eguchi,et al.  The Novel Synthesis of L -Hydroxyproline from D -Glutamic Acid , 1974 .

[20]  R. Lauffer,et al.  Targeted relaxation enhancement agents for MRI , 1991, Magnetic resonance in medicine.

[21]  Claudio Luchinat,et al.  Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent. , 2007, Inorganic chemistry.

[22]  A. Seelig,et al.  High Relaxivity for Monomeric Gd(DOTA)‐Based MRI Contrast Agents, Thanks to Micellar Self‐Organization , 1999 .

[23]  J. Serfaty,et al.  In Vivo Evaluation of a New Magnetic Resonance Imaging Contrast Agent (P947) to Target Matrix Metalloproteinases in Expanding Experimental Abdominal Aortic Aneurysms , 2010, Investigative radiology.

[24]  Peter Caravan,et al.  Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent. , 2008, Chemistry.

[25]  E. Küng,et al.  Bis(allyloxy)(diisopropylamino)phosphine as a new phosphinylation reagent for the phosphorylation of hydroxy functions , 1989 .

[26]  L. Helm,et al.  T1e in four Gd3+ chelates: LODEPR measurements and models for electron spin relaxation , 2002 .

[27]  Alain Borel,et al.  How does internal motion influence the relaxation of the water protons in Ln(III)DOTA-like complexes? , 2002, Journal of the American Chemical Society.

[28]  É. Tóth,et al.  The impact of rigidity and water exchange on the relaxivity of a dendritic MRI contrast agent. , 2002, Chemistry.

[29]  Peter Caravan,et al.  Synthesis and evaluation of a high relaxivity manganese(II)-based MRI contrast agent. , 2004, Inorganic chemistry.

[30]  Paul Bernard,et al.  The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents. , 2002, Journal of medicinal chemistry.

[31]  Peter Caravan,et al.  Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents. , 2009, Contrast media & molecular imaging.

[32]  Peter Caravan,et al.  Pulsed ENDOR Study of Water Coordination to Gd3+ Complexes in Orientationally Disordered Systems , 2004 .

[33]  G. Lipari Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules , 1982 .

[34]  A. Sherry,et al.  The Effect of the Amide Substituent on the Biodistribution and Tolerance of Lanthanide(III) DOTA-Tetraamide Derivatives , 2008, Investigative radiology.

[35]  R. Ranganathan,et al.  New multimeric magnetic resonance imaging agents. , 1998, Investigative radiology.

[36]  Peter Caravan,et al.  Species Dependence on Plasma Protein Binding and Relaxivity of the Gadolinium-Based MRI Contrast Agent MS-325 , 2006, Investigative radiology.

[37]  P. Caravan,et al.  A High Relaxivity Magnetic Resonance Imaging Contrast Agent Targeted to Serum Albumin , 2008 .

[38]  Peter Caravan,et al.  Protein binding to lanthanide(III) complexes can reduce the water exchange rate at the lanthanide. , 2007, Inorganic chemistry.

[39]  L. Helm,et al.  Structural and Dynamic Parameters Obtained from 17O NMR, EPR, and NMRD Studies of Monomeric and Dimeric Gd3+ Complexes of Interest in Magnetic Resonance Imaging: An Integrated and Theoretically Self-Consistent Approach1 , 1996 .

[40]  S. Morcos,et al.  Nephrogenic Gadolinium Biodistribution and Skin Cellularity Following a Single Injection of Omniscan in the Rat , 2010, Investigative radiology.

[41]  K. Binnemans,et al.  Gadolinium(III) complexes of mono- and diethyl esters of monophosphonic acid analogue of DOTA as potential MRI contrast agents: solution structures and relaxometric studies. , 2007, Dalton transactions.

[42]  Nicolaas Bloembergen,et al.  Proton Relaxation Times in Paramagnetic Solutions. Effects of Electron Spin Relaxation , 1961 .

[43]  X. Li,et al.  The Gd(3+) complex of a fatty acid analogue of DOTP binds to multiple albumin sites with variable water relaxivities. , 2001, Inorganic chemistry.

[44]  M. Botta,et al.  Structure and relaxivity of macrocyclic gadolinium complexes incorporating pyridyl and 4-morpholinopyridyl substituents , 1999 .

[45]  U. Schmidt,et al.  Enantioselective Syntheses of (R)- and (S)-Hexahydropyridazine-3-carboxylic Acid Derivatives , 1996 .

[46]  Peter Caravan,et al.  Probing the water coordination of protein-targeted MRI contrast agents by pulsed ENDOR spectroscopy. , 2005, Chemphyschem : a European journal of chemical physics and physical chemistry.

[47]  S. Rast,et al.  A general approach to the electronic spin relaxation of Gd(III) complexes in solutions. Monte Carlo simulations beyond the Redfield limit , 2001 .

[48]  V. Runge Gadolinium and nephrogenic systemic fibrosis. , 2009, AJR. American journal of roentgenology.

[49]  A. Sherry,et al.  Towards the rational design of magnetic resonance imaging contrast agents: isolation of the two coordination isomers of lanthanide DOTA-type complexes. , 2003, Angewandte Chemie.

[50]  Peter Caravan,et al.  High-Relaxivity Magnetic Resonance Imaging Contrast Agents Part 2: Optimization of Inner- and Second-Sphere Relaxivity , 2010, Investigative radiology.

[51]  Sophie Laurent,et al.  Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. , 2006, Contrast media & molecular imaging.

[52]  A. Szabó,et al.  Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity , 1982 .

[53]  Oleg G. Poluektov,et al.  High-field pulsed EPR and ENDOR of Gd3+ complexes in glassy solutions , 2005 .

[54]  M. Botta,et al.  Towards the rational design of MRI contrast agents: a practical approach to the synthesis of gadolinium complexes that exhibit optimal water exchange. , 2005, Dalton transactions.

[55]  Peter Caravan,et al.  Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. , 2006, Chemical Society reviews.

[56]  S Aime,et al.  pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. , 2001, Journal of the American Chemical Society.

[57]  L. Helm,et al.  Inorganic and bioinorganic solvent exchange mechanisms. , 2005, Chemical reviews.

[58]  Peter Caravan,et al.  The gadolinium(III)-water hydrogen distance in MRI contrast agents. , 2003, Inorganic chemistry.